Re: Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium

被引：1
|
作者：
Logothetis, Christopher J. [1 ]
Siefker-Radtke, Arlene [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Unit 1374, Dept Genitourinary Med Oncol, Houston, TX 77230 USA
来源：
EUROPEAN UROLOGY | 2010年 / 57卷 / 04期
关键词：
D O I：
10.1016/j.eururo.2010.01.029
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：728 / 729
页数：3
相关论文
共 50 条
  • [31] Gemcitabine and paclitaxel in previously treated patients with advanced transitional cell carcinoma
    Marini, L
    Sternberg, C
    Sella, A
    Calabro, F
    Van Rijn, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S348 - S349
  • [32] Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer
    Zanetta, G
    Lissoni, A
    Pellegrino, A
    Sessa, C
    Colombo, N
    Gueli-Alletti, D
    Mangioni, C
    ANNALS OF ONCOLOGY, 1998, 9 (09) : 977 - 980
  • [33] CHEMOTHERAPY FOR LOCALLY ADVANCED OR METASTATIC TRANSITIONAL CELL-CARCINOMA - AN OVERVIEW
    MEAD, G
    BRITISH JOURNAL OF CANCER, 1991, 63 (05) : 832 - 832
  • [34] Chemotherapy with cisplatin and paclitaxel in patients with locally advanced, recurrent or metastatic oesophageal cancer
    Petrasch, S
    Welt, A
    Reinacher, A
    Graeven, U
    König, M
    Schmiegel, W
    BRITISH JOURNAL OF CANCER, 1998, 78 (04) : 511 - 514
  • [35] Chemotherapy with cisplatin and paclitaxel in patients with locally advanced, recurrent or metastatic oesophageal cancer
    S Petrasch
    A Welt
    A Reinacher
    U Graeven
    M König
    W Schmiegel
    British Journal of Cancer, 1998, 78 : 511 - 514
  • [36] Cisplatin, paclitaxel and ifosfamide as a two-days neoadjuvant chemotherapy in bulky/locally advanced cervical carcinoma
    Savarese, Antonella
    Vizza, Enrico
    Felici, Alessandra
    Cutillo, Giuseppe
    Nuzzo, Carmen
    Di Segni, Costanza
    Sbiroli, Carlo
    Cognetti, Francesco
    ANNALS OF ONCOLOGY, 2006, 17 : 172 - 172
  • [37] M-VAC (METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN) FOR ADVANCED TRANSITIONAL CELL-CARCINOMA OF THE UROTHELIUM
    STERNBERG, CN
    YAGODA, A
    SCHER, HI
    WATSON, RC
    HERR, HW
    MORSE, MJ
    SOGANI, PC
    VAUGHAN, ED
    BANDER, N
    WEISELBERG, LR
    GELLER, N
    HOLLANDER, PS
    LIPPERMAN, R
    FAIR, WR
    WHITMORE, WF
    JOURNAL OF UROLOGY, 1988, 139 (03): : 461 - 469
  • [38] Gemcitabine, ifosfamide, and cisplatin combination (GIP) in treatment of patients with locally advanced or metastatic nonsmall cell lung cancer - Results of a phase II study
    Planchard, David
    Bourgeois, Hugues
    Adoun, Michele
    Paitel, Jean-Francois
    Blanc, Pierre
    Genet, Dominique
    Ferru, Aurelie
    Meurice, Jean-Chaude
    Deletage, Celine
    Tourani, Jean-Marc
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (04): : 345 - 351
  • [39] Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract -: Final report of a phase II trial evaluating two dosing schedules
    Bajorin, DF
    McCaffrey, JA
    Dodd, PM
    Hilton, S
    Mazumdar, M
    Kelly, WK
    Herrr, H
    Scher, HI
    Icasiano, E
    Higgins, G
    CANCER, 2000, 88 (07) : 1671 - 1678
  • [40] Amsacrine and cisplatin in poor prognosis patients with metastatic transitional cell carcinoma of the urothelium.
    Popov, I
    Jelic, S
    Nikolic-Tomasevic, Z
    Radosavljevic, D
    ANNALS OF ONCOLOGY, 2000, 11 : 78 - 78
12345